These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23357683)

  • 1. 3q26.33-3q27.2 microdeletion: a new microdeletion syndrome?
    Mandrile G; Dubois A; Hoffman JD; Uliana V; Di Maria E; Malacarne M; Coviello D; Faravelli F; Zwolinski S; Hellens S; Wright M; Forzano F
    Eur J Med Genet; 2013 Apr; 56(4):216-21. PubMed ID: 23357683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Description of another case of 3q26.33-3q27.2 microdeletion supports a recognizable phenotype.
    Zarate YA; Bell C; Schaefer B
    Eur J Med Genet; 2013 Nov; 56(11):624-5. PubMed ID: 24055528
    [No Abstract]   [Full Text] [Related]  

  • 3. Recurrent HERV-H-mediated 3q13.2-q13.31 deletions cause a syndrome of hypotonia and motor, language, and cognitive delays.
    Shuvarikov A; Campbell IM; Dittwald P; Neill NJ; Bialer MG; Moore C; Wheeler PG; Wallace SE; Hannibal MC; Murray MF; Giovanni MA; Terespolsky D; Sodhi S; Cassina M; Viskochil D; Moghaddam B; Herman K; Brown CW; Beck CR; Gambin A; Cheung SW; Patel A; Lamb AN; Shaffer LG; Ellison JW; Ravnan JB; Stankiewicz P; Rosenfeld JA
    Hum Mutat; 2013 Oct; 34(10):1415-23. PubMed ID: 23878096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Confirmation and further delineation of the 3q26.33-3q27.2 microdeletion syndrome.
    Dasouki M; Roberts J; Santiago A; Saadi I; Hovanes K
    Eur J Med Genet; 2014 Feb; 57(2-3):76-80. PubMed ID: 24462885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infantile presentation of 3q26.33-3q27.2 deletion syndrome.
    Robilliard R; Caylan M
    BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33257348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding the clinical phenotype at the 3q13.31 locus with a new case of microdeletion and first characterization of the reciprocal duplication.
    Vuillaume ML; Delrue MA; Naudion S; Toutain J; Fergelot P; Arveiler B; Lacombe D; Rooryck C
    Mol Genet Metab; 2013; 110(1-2):90-7. PubMed ID: 23920044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An interstitial de-novo microdeletion of 3q26.33q27.3 causing severe intrauterine growth retardation.
    Bouman A; Weiss M; Jansen S; Hankel M; Nieuwint A; Adriaanse B; van de Kamp J; Tan-Sindhunata G
    Clin Dysmorphol; 2015 Apr; 24(2):68-74. PubMed ID: 25714561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WAC loss-of-function mutations cause a recognisable syndrome characterised by dysmorphic features, developmental delay and hypotonia and recapitulate 10p11.23 microdeletion syndrome.
    DeSanto C; D'Aco K; Araujo GC; Shannon N; ; Vernon H; Rahrig A; Monaghan KG; Niu Z; Vitazka P; Dodd J; Tang S; Manwaring L; Martir-Negron A; Schnur RE; Juusola J; Schroeder A; Pan V; Helbig KL; Friedman B; Shinawi M
    J Med Genet; 2015 Nov; 52(11):754-61. PubMed ID: 26264232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A de novo 1.9-Mb interstitial deletion of 3q13.2q13.31 in a girl with dysmorphic features, muscle hypotonia, and developmental delay.
    Shimojima K; Saito K; Yamamoto T
    Am J Med Genet A; 2009 Aug; 149A(8):1818-22. PubMed ID: 19610083
    [No Abstract]   [Full Text] [Related]  

  • 10. A 137-kb deletion within the Potocki-Shaffer syndrome interval on chromosome 11p11.2 associated with developmental delay and hypotonia.
    Montgomery ND; Turcott CM; Tepperberg JH; McDonald MT; Aylsworth AS
    Am J Med Genet A; 2013 Jan; 161A(1):198-202. PubMed ID: 23239541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An additional patient with 3q27.3 microdeletion syndrome.
    Castori M; Bottillo I; Laino L; Morlino S; Grammatico B; Grammatico P
    J Child Neurol; 2015 Mar; 30(4):500-4. PubMed ID: 25038125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interstitial microdeletion of 17q11.2 is associated with hypotonia, fatigue, intellectual disability, and a subtle facial phenotype in three unrelated patients.
    Osio D; Rankin J; Koillinen H; Reynolds A; Van Esch H
    Am J Med Genet A; 2018 Jan; 176(1):209-213. PubMed ID: 29130599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and molecular delineation of the 17q21.31 microdeletion syndrome.
    Koolen DA; Sharp AJ; Hurst JA; Firth HV; Knight SJ; Goldenberg A; Saugier-Veber P; Pfundt R; Vissers LE; Destrée A; Grisart B; Rooms L; Van der Aa N; Field M; Hackett A; Bell K; Nowaczyk MJ; Mancini GM; Poddighe PJ; Schwartz CE; Rossi E; De Gregori M; Antonacci-Fulton LL; McLellan MD; Garrett JM; Wiechert MA; Miner TL; Crosby S; Ciccone R; Willatt L; Rauch A; Zenker M; Aradhya S; Manning MA; Strom TM; Wagenstaller J; Krepischi-Santos AC; Vianna-Morgante AM; Rosenberg C; Price SM; Stewart H; Shaw-Smith C; Brunner HG; Wilkie AO; Veltman JA; Zuffardi O; Eichler EE; de Vries BB
    J Med Genet; 2008 Nov; 45(11):710-20. PubMed ID: 18628315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between deletion size and important phenotypes expands the genomic region of interest in Phelan-McDermid syndrome (22q13 deletion syndrome).
    Sarasua SM; Dwivedi A; Boccuto L; Rollins JD; Chen CF; Rogers RC; Phelan K; DuPont BR; Collins JS
    J Med Genet; 2011 Nov; 48(11):761-6. PubMed ID: 21984749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The Phelan-McDermid syndrome (22q13 microdeletion) - case report].
    Slezak R; Laczmańska I
    Med Wieku Rozwoj; 2011; 15(1):96-100. PubMed ID: 21786519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Muscular hypotonia, developmental retardation, speech delay and mildly dysmorphic features: 22q13 deletion syndrome (Phelan-McDermid Syndrome) as an important differential diagnosis].
    Strenge S; Froster UG; Kujat A; Bernhard M; Merkenschlager A
    Klin Padiatr; 2008; 220(5):318-20. PubMed ID: 18814345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3q29 microdeletion syndrome: Cognitive and behavioral phenotype in four patients.
    Città S; Buono S; Greco D; Barone C; Alfei E; Bulgheroni S; Usilla A; Pantaleoni C; Romano C
    Am J Med Genet A; 2013 Dec; 161A(12):3018-22. PubMed ID: 24214349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five patients with novel overlapping interstitial deletions in 8q22.2q22.3.
    Kuechler A; Buysse K; Clayton-Smith J; Le Caignec C; David A; Engels H; Kohlhase J; Mari F; Mortier G; Renieri A; Wieczorek D
    Am J Med Genet A; 2011 Aug; 155A(8):1857-64. PubMed ID: 21739578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five children with deletions of 1p34.3 encompassing AGO1 and AGO3.
    Tokita MJ; Chow PM; Mirzaa G; Dikow N; Maas B; Isidor B; Le Caignec C; Penney LS; Mazzotta G; Bernardini L; Filippi T; Battaglia A; Donti E; Earl D; Prontera P
    Eur J Hum Genet; 2015 Jun; 23(6):761-5. PubMed ID: 25271087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical spectrum of individuals with de novo EBF3 variants or deletions.
    Nishi E; Uehara T; Yanagi K; Hasegawa Y; Ueda K; Kaname T; Yamamoto T; Kosaki K; Okamoto N
    Am J Med Genet A; 2021 Oct; 185(10):2913-2921. PubMed ID: 34050706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.